Restoring control of bowel and bladder function

Clinical-Stage Company | FDA-Cleared IND | NIH-Funded Phase 1 | >$20M NIH Funding

Our Approach

Current bowel and bladder management can require catheterization, laxatives, enemas, and manual bowel programs that may be invasive, time-consuming, and difficult to predict.


Dignify is developing short-acting pharmaceutical therapies designed to produce bowel and/or bladder emptying when needed, with the goal of giving patients greater control over the timing and location of voiding while reducing reliance on conventional management approaches.